Surveillance

Vancomycin-Resistant Enterococci (VRE) Infections - Surveillance results: 2015-2016

From April 1, 2015, to March 31, 2016, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,833,086 patient days (Table 1). In total, 78 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated VRE infection (cat. 1a and 1b) was 0.16 per 10…

Monitoring report

Hospital-Wide Healthcare-associated Bloodstream Infections: surveillance 2015-2016

From April 1st, 2015, to March 31st, 2016, 87 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,770,053 patient-days (Table 1). Participating facilities reported 3,173 BSIs in 2,948 patients. The total 2015-2016 incidence rate is 5.45 cases per 10,000 patient-days for all facilities participating in 2015-2016, and it is 5.35 for facilities…

Monitoring report

Clostridium difficile–Associated Diarrhea: surveillance 2015-2016

From April 1, 2015, to March 31, 2016, 95 healthcare facilities participated in the Clostridium difficile–associated diarrhea (CDAD) surveillance program, for a combined total of 5,048,411 inpatient days (Table 1). These participating facilities reported 2,977 cases of healthcare-associated CDAD (HA-CDAD). The incidence rate of HA-CDAD was 5.9 cases per 10,000 patient days. The 2015-2016 incidence rate was significantly lower than……

Monitoring report

Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections: Surveillance, 2015-2016

From April 1, 2015, to March 31, 2016, 89 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,851,752 inpatient days (Table 1). Together, these facilities reported 65 cases of healthcare-associated MRSA bloodstream infections (HA-MRSA-BSI). The incidence rate was 0.13 per 10,000 patient-days. This incidence rate of HA-MRSA-BSI has……

Monitoring report

Central Line–Associated Bloodstream Infections in Intensive Care Units: Surveillance 2015-2016

From April 1st, 2015, to March 31st, 2016, 66 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 128,035 catheter-days (Table 1). Participating ICUs reported 150 CLABSIs in 139 patients. Incidence rates are 0.70 per 1,000 catheter-days in teaching adult ICUs, 0.42 in non-teaching adult ICUs, 1.95 in pediatric ICUs and 4.15 in neonatal ICUs…

Monitoring report

Surveillance of Lyme disease and other diseases transmitted by the Ixodes scapularis tick: 2014

In 2014, 127 cases of Lyme disease were reported to public health authorities, including 66 cases that were acquired in Québec.

During that same year, the Laboratoire de santé publique du Québec received 2,549 Ixodes scapularis ticks from Québec, primarily from the Montérégie, Montréal, Mauricie and Centre-du-Québec, Lanaudière, Laurentides and Estrie regions.

Lastly, active surveillance in 2014…

Monitoring report

Preventing Intentional OTC Drug Overdoses

Each year in Québec, approximately 174 people commit suicide by drug overdose, of which at least 15 are the result of over-the-counter (OTC) drug overdoses. A substantial number of suicides and suicide attempts by overdose involve more than one substance. The number of suicides by OTC medication is under-estimated, since in cases where several drugs have been ingested, only the substance that is presumed to have caused the death is considered when determining the most likely cause of death…
Scientific advisory

Vascular Access–Related Bloodstream Infections in Hemodialysis Patients in Québec : surveillance results 2014–2015

From April 1st, 2014, to March 31st, 2015, 45 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 55,640 patient-periods (Table 1). Participating units reported 156 VARBSIs in 142 patients. The proportion of patient-periods involving a fistula accounted for 43.4%. The VARBSI incidence rate was 0.09 cases per 100 patient-periods…

Monitoring report

Central Line–Associated Bloodstream Infections in Intensive Care Units in Québec surveillance results : 2014–2015

From April 1st, 2014, to March 31st, 2015, 67 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 130,776 catheter-days. Participating ICUs reported 115 CLABSIs in 112 patients. Incidence rates were 0.34 per 1,000 catheter-days in coronary ICUs, 0.52 in teaching adult ICUs, 0.76 in non-teaching adult ICUs, 2.06 in pediatric ICUs and 2.20 in neonatal ICUs. The…

Monitoring report

Hospital-Wide Healthcare-associated Bloodstream Infections : surveillance results 2014–2015

From April 1st, 2014, to March 31st, 2015, 88 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,733,772 patient-days. Participating facilities reported 3,035 BSIs in 2,832 patients. The total incidence rate was 5.3 cases per 10,000 patient-days. The incidence rate in 2014–2015 was significantly lower compared to the average rate for 2010–2014 in facilities that…

Monitoring report